SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 369 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $202,000 | +47.4% | 1,829 | 0.0% | 0.00% | +100.0% |
| Q2 2022 | $137,000 | -17.5% | 1,829 | -13.9% | 0.00% | 0.0% |
| Q1 2022 | $166,000 | -23.5% | 2,124 | -11.1% | 0.00% | 0.0% |
| Q4 2021 | $217,000 | -25.9% | 2,389 | -24.5% | 0.00% | -50.0% |
| Q3 2021 | $293,000 | +7.3% | 3,166 | -9.9% | 0.00% | 0.0% |
| Q2 2021 | $273,000 | -75.1% | 3,512 | -76.1% | 0.00% | -71.4% |
| Q1 2021 | $1,096,000 | -55.0% | 14,712 | +2.8% | 0.01% | -58.8% |
| Q4 2020 | $2,436,000 | +5.9% | 14,305 | -12.7% | 0.02% | 0.0% |
| Q3 2020 | $2,300,000 | -19.4% | 16,377 | -8.0% | 0.02% | -26.1% |
| Q2 2020 | $2,855,000 | +33.9% | 17,800 | -18.3% | 0.02% | +109.1% |
| Q1 2020 | $2,132,000 | +46.2% | 21,800 | +92.9% | 0.01% | 0.0% |
| Q4 2019 | $1,458,000 | +321.4% | 11,300 | +145.7% | 0.01% | +266.7% |
| Q3 2019 | $346,000 | – | 4,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |